Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations

British Journal of Haematology

Volumn 157, Issue 5, 2012, Pages 647-650

  Matsuda, Kazuyuki ^a   Yoshida, Nao ^b   Miura, Shuhei ^a   Nakazawa, Yozo ^c   Sakashita, Kazuo ^c   Hyakuna, Nobuyuki ^d   Saito, Masahiro ^e   Kato, Fumiyo ^f   Ogawa, Atsushi ^g   Watanabe, Akihiro ^g   Sotomatsu, Manabu ^h   Kobayashi, Chie ⁱ   Ito, Toshiro ^c   Ishida, Fumihiro ^c   Manabe, Atsushi ^j   Kojima, Seiji ^k   Koike, Kenichi ^c  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g NIIGATA CANCER CENTER HOSPITAL   (Japan)

^h Gumna Children S Medical Center   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

^j ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^k NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

CBL; JMML; PTPN11; RAS; Spliceosome related mutations

Indexed keywords

GENOMIC DNA;

ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER MORTALITY; CAUSE OF DEATH; CELL PROLIFERATION; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; EXON; GENE MUTATION; HEMATOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LETTER; LONG TERM CARE; MYELODYSPLASTIC SYNDROME; ONCOGENE; ONCOGENE CBL; ONCOGENE K RAS; ONCOGENE NF1; ONCOGENE PTPN11; ONCOGENE SF3B1; ONCOGENE SRSF2; ONCOGENE U2AF1; ONCOGENE ZRSR2; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLICEOSOME;

FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; MALE; MUTATION; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEINS;

EID: 84860838806     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09063.x     Document Type: Letter

References (10)

1. Flotho, C., Kratz, C.P., Bergsträsser, E., Hasle, H., Starý, J., Trebo, M., van den Heuvel-Eibrink, M.M., Wójcik, D., Zecca, M., Locatelli, F. & Niemeyer, C.M. (2008) Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations. Blood, 111, 966-967.
2. Koike, K. & Matsuda, K. (2008) Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. British Journal of Haematology, 141, 567-575.
3. Locatelli, F., Nöllke, P., Zecca, M., Korthof, E., Lanino, E., Peters, C., Pession, A., Kabisch, H., Uderzo, C., Bonfim, C.S., Bader, P., Dilloo, D., Stary, J., Fischer, A., Révész, T., Führer, M., Hasle, H., Trebo, M., van den Heuvel-Eibrink, M.M., Fenu, S., Strahm, B., Giorgiani, G., Bonora, M.R., Duffner, U. & Niemeyer, C.M. (2005) Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood, 105, 410-419.
4. Loh, M.L. (2011) Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. British Journal of Haematology, 152, 677-687.
5. Matsuda, K., Shimada, A., Yoshida, N., Ogawa, A., Watanabe, A., Yajima, S., Iizuka, S., Koike, K., Yanai, F., Kawasaki, K., Yanagi-machi, M., Kikuchi, A., Ohtsuka, Y., Hidaka, E., Yamauchi, K., Tanaka, M., Yanagisawa, R., Nakazawa, Y., Shiohara, M., Manabe, A., Kojima, S. & Koike, K. (2007) Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood, 109, 5477-5480.
6. Matsuda, K., Taira, C., Sakashita, K., Saito, S., Tanaka-Yanagisawa, M., Yanagisawa, R., Nakazawa, Y., Shiohara, M., Fukushima, K., Oda, M., Honda, T., Nakahata, T. & Koike, K. (2010) Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations. Blood, 115, 5429-5431.
7. Muramatsu, H., Makishima, H., Jankowska, A.M., Cazzolli, H., O'Keefe, C., Yoshida, N., Xu, Y., Nishio, N., Hama, A., Yagasaki, H., Takahashi, Y., Kato, K., Manabe, A., Kojima, S. & Maciejewski, J.P. (2010) Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Blood, 115, 1969-1975.
8. Niemeyer, C.M., Kang, M.W., Shin, D.H., Furlan, I., Erlacher, M., Bunin, N.J., Bunda, S., Finklestein, J.Z., Sakamoto, K.M., Gorr, T.A., Mehta, P., Schmid, I., Kropshofer, G., Corbacioglu, S., Lang, P.J., Klein, C., Schlegel, P.G., Heinzmann, A., Schneider, M., Starý, J., van den Heuvel-Eibrink, M.M., Hasle, H., Locatelli, F., Sakai, D., Archambeault, S., Chen, L., Russell, R.C., Sybingco, S.S., Ohh, M., Braun, B.S., Flotho, C. & Loh, M.L. (2010) Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nature Genetics, 42, 794-800.
9. Pérez, B., Mechinaud, F., Galambrun, C., Ben Romdhane, N., Isidor, B., Philip, N., Derain-Court, J., Cassinat, B., Lachenaud, J., Kaltenbach, S., Salmon, A., Désirée, C., Pereira, S., Menot, M.L., Royer, N., Fenneteau, O., Baruchel, A., Chomienne, C., Verloes, A. & Cavé, H. (2010) Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. Journal of Medical Genetics, 47, 686-691.
10. Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., Chalkidis, G., Suzuki, Y., Shiosaka, M., Kawahata, R., Yamaguchi, T., Otsu, M., Obara, N., Sakata-Yanagimoto, M., Ishiyama, K., Mori, H., Nolte, F., Hofmann, W.K., Miyawaki, S., Sugano, S., Haferlach, C., Koeffler, H.P., Shih, L.Y., Haferlach, T., Chiba, S., Nakauchi, H., Miyano, S. & Ogawa, S. (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature, 478, 64-69.